Need help? Our team of experienced experts is here for you with full support.
AKA-174
Tirzepatide
Cat. No.
AKA-174
CAS No.
2023788-19-2
MF
C225H348N48O68
MW
4813.53
Tirzepatide is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Tirzepatide
CAS No.
2023788-19-2
MF
C225H348N48O68
MW
4813.53
Specification
98%
Research Area
GIP/GLP-1 receptors Agonist,obesity and type 2 diabetes
Description
Tirzepatide is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: Under Development (current pilot scale, production validation in 3-4 month, DMF filing in 12 month)
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Fontanella RA, et al. Tirzepatide prevents neurodegeneration through multiple molecular pathways. Journal of Translational Medicine. 2024 Jan 29;22(1):114.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.